| PAM | pancreatic acinar mass; penicillin aluminum monostearate; peptidylglycine alpha-amidating monooxygen... |
|---|---|
| PM | after death (Lat. post mortem); after noon [Lat. post meridiem]; mean pressure; pacemaker; pantomogr... |
| SM | Master of Science; sadomasochism; self-monitoring; silicon microphysiometer; simple mastectomy; skim... |
| TM | technology management; tectorial membrane; temperature by mouth; temporalis muscle; temporomandibula... |
| CGRP | Calcitonin Gene Related Peptide(Protein) |
| environmental medicine | Medical specialty concerned with environmental factors that may impinge upon human disease, and development of methods for the detection, prevention, and control of environmentally related disease. (12 Dec 1998) |
|---|---|
| tropical medicine | <study> The branch of medicine concerned with diseases, mainly of parasitic origin, common in tropical and subtropical regions. (12 Dec 1998) |
| evidence-based medicine | The process of systematically finding, appraising, and using contemporaneous research findings as the basis for clinical decisions. Evidence-based medicine asks questions, finds and appraises the relevant data, and harnesses that information for everyday clinical practice. Evidence-based medicine follows four steps: formulate a clear clinical question from a patient's problem; search the literature for relevant clinical articles; evaluate (critically appraise) the evidence for its validity and usefulness; implement useful findings in clinical practice. The term "evidence based medicine" (no hyphen) was coined at mcmaster medical school in canada in the 1980's to label this clinical learning strategy, which people at the school had been developing for over a decade. (12 Dec 1998) |
| experimental medicine | The scientific investigation of medical problems by experimentation upon animals or by clinical research. (05 Mar 2000) |
| family medicine | The medical specialty concerned with providing continuous, comprehensive care to all age groups, from first patient contact to terminal care, with special emphasis on care of the family as a unit. (05 Mar 2000) |
| foetal medicine | Study of the growth, development, care, and treatment of the foetus, and of environmental factors harmful to the foetus. Synonym: fetology. (05 Mar 2000) |
| folk medicine | Treatment of ailments outside of organised medicine by remedies and simple measures based upon experience and knowledge handed on from generation to generation. (05 Mar 2000) |
| forensic medicine | The application of medical knowledge to questions of law. (12 Dec 1998) |
| legal medicine | The application of medical knowledge to questions of law. (12 Dec 1998) |
| allelic gene | See: allele, dominance of traits. (05 Mar 2000) |
| antibiotic resistance gene | Genes in a microorganism which confer resistance to antibiotics, for example by coding for enzymes which destroy it, by coding for surface proteins which prevent it from entering the microorganism, or by being a mutant form of the antibiotic's target so that it can ignore it. (09 Oct 1997) |
| autosomal gene | A gene located on any chromosome other than the sex chromosomes (X or Y). (05 Mar 2000) |
| bicoid gene | A group of genes which are important to the proper development of the head and thorax in the embryo of the fruit fly Drosophila melanogaster. (09 Oct 1997) |
| BRCA1 breast cancer susceptibility gene | This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer. (12 Dec 1998) |
| calcitonin gene-related peptide | <protein> A second product transcribed from the calcitonin gene. Calcitonin gene related peptide is found in a number of tissues including nervous tissue. It is a vasodilator that may participate in the cutaneous triple response. It is a neuropeptide of 37 amino acids with structural homology to salmon calcitonin. Co-localises with substance P in neurons. It occurs as a result of alternative processing of mRNA from the calcitonin gene. The neuropeptide is widely distributed in neural tissue of the brain, gut, perivascular nerves, and other tissue. The peptide produces multiple biological effects and has both circulatory and neurotransmitter modes of action. In particular, it is a potent endogenous vasodilator. Intracerebral administration leads to a rise in noradrenergic sympathetic outflow, a rise in blood pressure and a fall in gastric secretion. Acronym: CGRP (05 May 2002) |